 LAVAL, QC and CAMBRIDGE, England, Nov. 10, 2020 PRNewswire - Liminal BioSciences Inc. Nasdaq: LMNL Liminal BioSciences or the Company, a clinical-stage biopharmaceutical company, today announced that it will now report its financial results for the third quarter ended September... 